Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.52 is 15% above its 5-year average of 3.07, around the middle of its 5-year range (2.39–4.12).
As of the fiscal period ended Tuesday, June 30, 2026. 1.98% below its 12-month average of 3.59.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.52.
CURRENT RATIO
3.52
CURRENT RATIO AVG TTM
3.59
CURRENT RATIO AVG 3Y
3.29
CURRENT RATIO AVG 5Y
3.07
CURRENT RATIO AVG 10Y
2.29
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-1.98%
CURRENT VS 3Y AVG
+6.75%
CURRENT VS 5Y AVG
+14.61%
CURRENT VS 10Y AVG
+53.52%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.48
median of 692 covered companies
CURRENT VS SECTOR MEDIAN
+1.19%
vs the sector median at left
Organogenesis Holdings Inc.
Market Cap
$169.21M
Current Ratio
3.52
TTM Avg
3.59
3Y Avg
3.29
5Y Avg
3.07
Market Cap
$173.76M
Current Ratio
3.49
TTM Avg
3.52
3Y Avg
4.49
5Y Avg
5.44
Market Cap
$174.58M
Current Ratio
12.82
TTM Avg
9.83
3Y Avg
6.43
5Y Avg
5.45
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Organogenesis Holdings Inc. (ORGO) | $169.21M | 3.52 | 3.59 | 3.29 | 3.07 |
| OptimizeRx Corp. (OPRX)vs › | $167.32M | 5.58 | 2.96 | 5.18 | 6.05 |
| MediWound Ltd. (MDWD)vs › | $172.45M | 2.32 | 2.15 | 3.17 | 2.88 |
| Nkarta, Inc. (NKTX)vs › | $172.78M | 7.98 | 13.57 | 13.59 | 18.24 |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | 3.49 | 3.52 | 4.49 | 5.44 |
| Coherus Oncology, Inc. (CHRS)vs › | $164.54M | 1.77 | 1.33 | 1.71 | 2.63 |
| PepGen Inc. (PEPG)vs › | $163.59M | 13.36 | 9.68 | 8.92 | 10.26 |
| Precision BioSciences, Inc. (DTIL)vs › | $174.58M | 12.82 | 9.83 | 6.43 | 5.45 |
| Cue Biopharma, Inc. (CUE)vs › | $175.51M | 1.25 | 2.29 | 3.57 | 4.16 |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.19M | 11.22 | 14.99 | 15.44 | 13.43 |
Current Ratio
3.52
Quick Ratio
3.00
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.52 |
| 2026-03-31 | 3.53 |
| 2025-12-31 | 3.62 |
| 2025-09-30 | 3.32 |
| 2025-06-30 | 3.95 |
| 2025-03-31 | 4.12 |
| 2024-12-31 | 3.69 |
| 2024-09-30 | 3.09 |
| 2024-06-30 | 2.73 |
| 2024-03-31 | 2.74 |
| 2023-12-31 | 2.80 |
| 2023-09-30 | 2.77 |
| 2023-06-30 | 2.95 |
| 2023-03-31 | 2.85 |
| 2022-12-31 | 2.97 |
| 2022-09-30 | 2.58 |
| 2022-06-30 | 2.62 |
| 2022-03-31 | 2.84 |
| 2021-12-31 | 2.74 |
| 2021-09-30 | 2.62 |
| 2021-06-30 | 2.39 |
| 2021-03-31 | 2.50 |
| 2020-12-31 | 2.56 |
| 2020-09-30 | 1.95 |
| 2020-06-30 | 1.78 |
| 2020-03-31 | 2.03 |
| 2019-12-31 | 2.10 |
| 2019-09-30 | 1.43 |
| 2019-06-30 | 1.51 |
| 2019-03-31 | 1.63 |
| 2018-12-31 | 1.07 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.03 |
| 2018-03-31 | 0.05 |
| 2017-12-31 | 0.07 |
| 2017-09-30 | 0.13 |
| 2017-06-30 | 7.02 |
| 2017-03-31 | 6.25 |
| 2016-12-31 | 3.00 |
| 2016-09-30 | 2.88 |
| 2016-06-30 | 0.17 |
| 2016-03-31 | 0.00 |
